CoChat

The multiple facets of drug resistance: one history, different approaches

Open access
Niero, Evandro Luís, Rocha-Sales, Bianca, Lauand, Camila, Cortez, Beatriz Araujo, de Souza, Marcelo Medina, Rezende-Teixeira, Paula, Urabayashi, Marcel Shiniti, Martens, Adam Arai, Neves, Jorge Henrique, Machado-Santelli, Gláucia Maria · 2014 · Journal of Experimental & Clinical Cancer Research
Cited by 137

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Some cancers like melanoma and pancreatic and ovarian cancers, for example, commonly display resistance to chemotherapy, and this is the major obstacle to a better prognosis of patients. Frequently, literature presents studies in monolayer cell cultures, 3D cell cultures or in vivo studies, but rarely the same work compares results of drug resistance in different models. Several of these works are presented in this review and show that usually cells in 3D culture are more resistant to drugs than monolayer cultured cells due to different mechanisms. Searching for new strategies to sensitize different tumors to chemotherapy, many methods have been studied to understand the mechanisms whereby cancer cells acquire drug resistance. These methods have been strongly advanced along the years and therapies using different drugs have been increasingly proposed to induce cell death in resistant cells of different cancers. Recently, cancer stem cells (CSCs) have been extensively studied because they would be the only cells capable of sustaining tumorigenesis. It is believed that the resistance of CSCs to currently used chemotherapeutics is a major contributing factor in cancer recurrence and later metastasis development. This review aims to appraise the experimental progress in the study of acquired drug resistance of cancer cells in different models as well as to understand the role of CSCs as the major contributing factor in cancer recurrence and metastasis development, describing how CSCs can be identified and isolated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-9966-33-37

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 137

Metadata

Authors
Niero, E. L., Rocha-Sales, B., Lauand, C., Cortez, B. A., de Souza, M. M., Rezende-Teixeira, P., Urabayashi, M. S., Martens, A. A., Neves, J. H., & Machado-Santelli, G. M.
Venue
Journal of Experimental & Clinical Cancer Research
Published
2014-04-28
Volume
33
Issue
1
Pages
37-37
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W2102275220
Cited by
137
References
16
FWCI
8.47
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The multiple facets of drug resistance: one history, different approaches. https://app.cochat.ai/papers/10.1186/1756-9966-33-37
The paper
Niero, E. L., Rocha-Sales, B., Lauand, C., Cortez, B. A., de Souza, M. M., Rezende-Teixeira, P., Urabayashi, M. S., Martens, A. A., Neves, J. H., & Machado-Santelli, G. M. (2014). The multiple facets of drug resistance: one history, different approaches. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/1756-9966-33-37

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.